0534 Efficacy and safety of switching from reference ustekinumab to its biosimilar for the treatment of plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S92
DOI: 10.1016/j.jid.2026.06.565 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von L. Ghanem und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ghanem, L., Cevallos-Cueva, M., Kirmani, N., Aktas, S., Streher, L. F., Santros, A., & Saucedo, C. M. D. O. (2026). 0534 Efficacy and safety of switching from reference ustekinumab to its biosimilar for the treatment of plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials. Journal of Investigative Dermatology, 146(8), S92. https://doi.org/10.1016/j.jid.2026.06.565
Vancouver
Ghanem L, Cevallos-Cueva M, Kirmani N, Aktas S, Streher LF, Santros A, et al. 0534 Efficacy and safety of switching from reference ustekinumab to its biosimilar for the treatment of plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials. Journal of Investigative Dermatology. 2026;146(8):S92. doi:10.1016/j.jid.2026.06.565
BibTeX
@article{Ghanem2026,
author = {Ghanem, L. and Cevallos-Cueva, M. and Kirmani, N. and Aktas, S. and Streher, L. Fenalte and Santros, A. and Saucedo, C. Montes de Oca},
title = {0534 Efficacy and safety of switching from reference ustekinumab to its biosimilar for the treatment of plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S92},
doi = {10.1016/j.jid.2026.06.565}
}
EUVIMED